0000899243-22-027733.txt : 20220804
0000899243-22-027733.hdr.sgml : 20220804
20220804210936
ACCESSION NUMBER: 0000899243-22-027733
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220802
FILED AS OF DATE: 20220804
DATE AS OF CHANGE: 20220804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hannan Kathy Hopinkah
CENTRAL INDEX KEY: 0001767813
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40097
FILM NUMBER: 221138360
MAIL ADDRESS:
STREET 1: ANNALY CAPITAL MANAGEMENT, INC.
STREET 2: 1211 AVE. OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ginkgo Bioworks Holdings, Inc.
CENTRAL INDEX KEY: 0001830214
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 872652913
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 27 DRYDOCK AVENUE
STREET 2: 8TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: (877) 442-5362
MAIL ADDRESS:
STREET 1: 27 DRYDOCK AVENUE
STREET 2: 8TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: Soaring Eagle Acquisition Corp.
DATE OF NAME CHANGE: 20210210
FORMER COMPANY:
FORMER CONFORMED NAME: Spinning Eagle Acquisition Corp.
DATE OF NAME CHANGE: 20201027
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-02
0
0001830214
Ginkgo Bioworks Holdings, Inc.
DNA
0001767813
Hannan Kathy Hopinkah
C/O GINKGO BIOWORKS HOLDINGS, INC.
27 DRYDOCK AVENUE
BOSTON
MA
02210
1
0
0
0
Class A Common Stock
2022-08-02
4
A
0
56986
0.00
A
61986
D
Stock Option
2.03
2022-08-02
4
A
0
84216
0.00
A
2032-08-02
Class A Common Stock
84216
84216
D
Stock Option
2.14
2022-08-02
4
A
0
186915
0.00
A
2032-08-02
Class A Common Stock
186915
186915
D
Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock. The vesting date of the RSUs and additional stock options, and in the case of the additional stock options, the exercise date, will be the day immediately prior to the date of the next Annual Meeting of Shareholders of the Issuer occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.
In accordance with the Non-Employee Director Compensation Program of the Issuer, the Black-Scholes value of the option award as of the grant date is a prorated amount based on $200,000.
The initial stock options shall vest and become exercisable in substantially equal installments on each of the first three anniversaries of the date of grant, such that the initial stock options shall be fully vested on the third anniversary of the date of grant, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.
In accordance with the Non-Employee Director Compensation Program of the Issuer, the Black-Scholes value of the option award as of the grant date is $400,000.
/s/ Karen Tepichin, Attorney-in-Fact
2022-08-04